razoxane has been researched along with dacarbazine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Carter, SK; Slavik, M | 1 |
| Brunner, KW; Cavalli, F | 1 |
| Cavalli, F | 1 |
| Ahmann, DL; Bisel, HF; Edmonson, JH; Frytak, S; Kvols, LK; Rubin, J | 1 |
| Elliott, P; Madden, FJ; Mould, RF; Newlands, ES; Newton, KA; Oon, CJ; Roberts, JT; Topham, C; Westbury, G | 1 |
| Giraldi, T; Grill, V; Mallardi, F; Perissin, L; Zorzet, S | 1 |
| Olweny, CL | 1 |
| Engstrom, PF; Klaassen, DJ; MacIntyre, JM; Mittelman, A | 1 |
| Cherubino, R; Giraldi, T; Mitri, E; Sava, G | 1 |
| Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL | 1 |
| Bamberg, M; Holfeld, H | 1 |
| Garbisa, S; Giraldi, T; Onisto, M; Perissin, L; Peron, A; Rapozzi, V; Zorzet, S | 1 |
2 review(s) available for razoxane and dacarbazine
| Article | Year |
|---|---|
Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
Topics: Altretamine; Animals; Antineoplastic Agents; Asparaginase; Azacitidine; Bleomycin; Cisplatin; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Guanazole; Humans; Ifosfamide; Male; National Institutes of Health (U.S.); Neoplasms; Nitrogen Mustard Compounds; Nitrosourea Compounds; Razoxane; United States | 1977 |
[New substances in oncologic therapy].
Topics: Alkylating Agents; Altretamine; Antimetabolites, Antineoplastic; Cisplatin; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Etoposide; Humans; Neoplasms; Nitrosourea Compounds; Razoxane; Tamoxifen; Vinca Alkaloids; Zinostatin | 1978 |
4 trial(s) available for razoxane and dacarbazine
| Article | Year |
|---|---|
[New substances in oncologic therapy].
Topics: Altretamine; Ancitabine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cisplatin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Mitolactol; Nitrosourea Compounds; Razoxane; Remission, Spontaneous; Tamoxifen; Time Factors; Vinca Alkaloids; Zinostatin | 1978 |
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
Topics: Antigens, Neoplasm; BCG Vaccine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Immunotherapy; Male; Melanoma; Piperazines; Prognosis; Razoxane; Triazenes | 1976 |
Management of Kaposi's sarcoma. Chemotherapy II.
Topics: Bleomycin; Carmustine; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Humans; Razoxane; Sarcoma, Kaposi; Uganda; Vincristine | 1981 |
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Male; Middle Aged; Mitomycins; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors | 1984 |
8 other study(ies) available for razoxane and dacarbazine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
Topics: Cisplatin; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Kidney; Male; Melanoma; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous; Triazenes | 1978 |
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
Topics: Animals; Dacarbazine; Hemorrhage; Lung Neoplasms; Mice; Neoplasm Metastasis; Piperazines; Razoxane; Triazenes | 1987 |
Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Tests; Cyclophosphamide; Dacarbazine; Female; Fibrinogen; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Piperazines; Platelet Aggregation; Platelet Count; Razoxane; Triazenes | 1984 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Rats; Razoxane; Teniposide | 1982 |
[General principles and new trends of cytostatic tumor therapy].
Topics: Antineoplastic Agents; Cisplatin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Radiation-Sensitizing Agents; Razoxane | 1980 |
Suppression of metastatic potential and up-regulation of gelatinases and uPA in LLC by protracted in vivo treatment with dacarbazine or razoxane.
Topics: Animals; Collagenases; Dacarbazine; Gelatinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Immunosuppression Therapy; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Razoxane; RNA, Messenger; Transcription, Genetic; Urokinase-Type Plasminogen Activator | 1997 |